Shattuck Labs, Inc. (STTK)
After hours:
| Previous close | 4.4300 |
| Open | 4.5400 |
| Bid | 4.3700 x 300 |
| Ask | 4.4300 x 200 |
| Day's range | 4.3700 - 4.5900 |
| 52-week range | 1.3300 - 11.7600 |
| Volume | |
| Avg. volume | 471,820 |
| Market cap | 209.699M |
| Beta (5Y monthly) | 1.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.9300 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 11.00 |
Simply Wall St.Is Shattuck Labs (NASDAQ:STTK) In A Good Position To Deliver On Growth Plans?
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
ZacksKymera Therapeutics (KYMR) Surges 23.4%: Is This an Indication of Further Gains?
Kymera Therapeutics (KYMR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
GlobeNewswireShattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes
AUSTIN, TX & DURHAM, NC, July 01, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced its addition to the Russell 2000® and Russell 3000® Indexes at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution. Shattuck’s addition will be effective today
